摘要
目的:对异甘草酸镁治疗脂肪性肝病的疗效进行分析和探讨。方法:收治脂肪性肝病患者60例,随机分为两组,观察组接受异甘草酸镁的治疗,对照组接受一般保肝药的治疗,对比临床疗效。结果:观察组TC、TG、AST、ALT均优于对照组(P<0.05),观察组治疗总有效率86.67%,高于对照组的63.33%,组间比较,差异有统计学意义(P<0.05)。结论:异甘草酸镁治疗脂肪性肝病疗效显著,可有效改善患者肝功能,提高治疗有效率。
Objective:To analyze and investigate the effect of magnesium isoglycyrrhizinate in the treatment of patients with fattyliver disease.Methods:60 patients with fatty liver disease were selected.They were randomly divided into the two groups.Theobservation group was treated by magnesium isoglycyrrhizinate,while the treatment group received general hepatoprotectantstreatment.We compared the clinical efficacy.Results:The levels of TC,TG,AST,ALT in the observation group were significantlybetter than those in the control group(P<0.05).The total effective rate of the observation group was 86.67%,higher than 63.33% ofthe control group,and there was significant difference between groups(P<0.05).Conclusion:The effect of magnesiumisoglycyrrhizinate in the treatment of patients with fatty liver disease is significant,which can effectively improve the patients withliver function,improve the efficiency of treatment.
作者
邵剑锋
Shao Jianfeng(Department of Infectious Disease,the People's Hospital of Jingjiang City 214500)
出处
《中国社区医师》
2016年第22期66-66,68,共2页
Chinese Community Doctors
关键词
异甘草酸镁
烯磷脂酰胆碱胶囊
脂肪性肝病
Magnesium isoglycyrrhizinate
Lecithin phosphatidylcholine capsules
Fatty liver disease